Treace Medical Concepts, Inc.
Mark Hair has over 25 years of work experience, with significant roles in finance and accounting. Mark is currently the Chief Financial Officer at Treace Medical Concepts, Inc. Prior to that, they served as the Chief Financial Officer at Restoration Robotics from 2018 to 2020. Mark also held the position of Vice President, Chief Accounting Officer at ZELTIQ from 2016 to 2017 and Vice President of Finance at Accuray in 2016. Mark has also worked as Vice President, Corporate Controller at Thoratec from 2014 to 2016 and Senior Vice President of Finance & Corporate Controller at Diamond Foods, Inc. from 2012 to 2014. Earlier in their career, Mark was a Partner at StoneTurn Group LLP from 2005 to 2012. Mark started their career at Deloitte, where they worked as Staff through Senior Manager from 1996 to 2004.
Mark Hair completed their education in 1995, obtaining a Bachelor of Science (B.S.) degree, as well as a Master in Accountancy (MAcc), from Brigham Young University. Their field of study during this period was accounting.
This person is not in any offices
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.